The FDA recently approved the Medtronic Prestige LP Cervical System for treating degenerative disc disease at two adjacent vertebral levels (between C3 and C7). The device is said to be Medtronic’s ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it has received approval from the U.S. Food and Drug Administration to market the PRESTIGE ...

MEMPHIS, TENN. - July 28, 2014 - Medtronic, Inc. (MDT) announces that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc System for the ...

Medtronic plc announced the US Food and Drug Administration's (FDA) approval of the Prestige LP Cervical Disc for the treatment of cervical disc disease causing nerve or spinal cord compression at two ...

Medtronic ($MDT) won FDA approval for its next-generation artificial disc for adult patients with neck pain or spinal cord injuries. The news is a feather in the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The U.S. Food and Drug Administration has issued an ...

Spinal implant specialist LDR has been held back by patchy insurance company reimbursement of its flagship device, demonstrating the challenges facing med tech companies as they navigate the tricky ...

MVM Life Science Partners has closed a $233 million fourth fund to invest in technologies, therapeutics, medical devices and healthcare IT companies. The London-based firm expects to do deals ranging ...

SAN FRANCISCO (MarketWatch) -- Medtronic Inc. said Monday that it has begun enrollment in the Prestige LP cervical disc clinical trial, the company's third major artificial cervical disc trial ...

The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...